OXYTROL
Oxybutynin
- Strength
- 3.9 mg/d
- Form
- Patch
- Class
- Cholinergic Muscarinic Antagonist
Allergan, Inc.
Oxybutynin
Listed by Allergan, Inc.
| Dosage form | Patch |
|---|---|
| Route | Transdermal |
| Drug class | Cholinergic Muscarinic Antagonist |
| Approval route | NDA — original brand approval |
| NDC code | 0023-9637 |
| FDA application | NDA202211 |
| RxNorm concept | 403799 |
| Package sizes listed | 2 |
| Marketed since | January 2016 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Oxybutynin
Allergan, Inc.
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.